New diabetes clinical trial: LEAN Mass Preservation with Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy

Published on: March 19, 2025 at 11:00PM
Conditions: Type 2 Diabetes Mellitus (T2DM)
Interventions: Behavioral: Resistance exercise; Dietary Supplement: Protein Intake; Combination Product: Resistance exercise + protein intake
Sponsors: Dasman Diabetes Institute; University of Glasgow
Not yet recruiting
https://ift.tt/ymhNSVl